metastatic breast cancer.
Showing 1 - 25 of >10,000
HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)
Not yet recruiting
- HER2-positive Breast Cancer
- Trastuzumab deruxtecan
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Aug 7, 2023
Metastatic Breast Cancer Trial (Meritup oral solution)
Not yet recruiting
- Metastatic Breast Cancer
- Meritup oral solution
- (no location specified)
Nov 29, 2023
Metastatic Breast Cancer Trial in Al Madinah (Palbociclib)
Not yet recruiting
- Metastatic Breast Cancer
-
Al Madīnah, AL, Saudi ArabiaAsmaa Imam Ahmed
Oct 8, 2023
Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago
Not yet recruiting
- Estrogen-receptor-positive Breast Cancer
- +3 more
- elacestrant, palbociclib, abemaciclib, ribociclib
-
Chicago, IllinoisNorthwestern University
Sep 25, 2023
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul
Recruiting
- Breast Cancer
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)
Not yet recruiting
- Metastatic Breast Cancer
- Lobular Breast Carcinoma
- Blood Specimen
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 19, 2023
Discovering Factors in Metastatic Breast Cancer Patients'
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Feb 25, 2023
Breast Cancer, Lipid Cell; Tumor, Nutrition Related Cancer Trial in Roma (Lipidomic analysis for breast cancer patients)
Not yet recruiting
- Breast Cancer
- +3 more
- Lipidomic analysis for breast cancer patients
-
Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Sep 4, 2023
HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,
Not yet recruiting
- HER2-PositiveRecurrent or Metastatic Breast Cancer
- SHR-A1811 Injection
- +2 more
- (no location specified)
Sep 21, 2023
Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Jul 12, 2023
Adverse Events, Produced by Antibodies Conjugates, on Quality of
Not yet recruiting
- Metastatic Breast Cancer
-
Aviano, Pordenone, Italy
- +2 more
Oct 24, 2023
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Not yet recruiting
- Metastatic Breast Cancer
-
Kingston, Ontario, Canada
- +1 more
Mar 27, 2023
Breast Cancer Trial in New York (Multicomponent Adherence Intervention)
Recruiting
- Breast Cancer
- Multicomponent Adherence Intervention
-
New York, New YorkColumbia University Medical Center
Nov 6, 2023
Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)
Recruiting
- Breast Cancer
- metronomic oral vinorelbine plus anlotinib
-
Xi'an, Shaanxi, ChinaXi'an International Medical Center Hospital
Aug 27, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)
Recruiting
- Metastatic Breast Cancer
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 26, 2023
DESTINY Breast Respond HER2-low Europe
Not yet recruiting
- Unresectable Breast Cancer
- +2 more
- Trastuzumab deruxtecan
- (no location specified)
Jul 6, 2023
Ribociclib in Combination With Hormonal Therapy in HR+/HER2-
Not yet recruiting
- Breast Cancer
- ribociclib
- (no location specified)
Oct 10, 2023
Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)
Recruiting
- Liver Metastases
- Breast Cancer
- Quiremspheres™
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Nov 16, 2023
Breast Cancer Trial (Disitamab Vedotin+Anlotinib)
Not yet recruiting
- Breast Cancer
- Disitamab Vedotin+Anlotinib
- (no location specified)
Aug 14, 2023
Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- Milademetan
- Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
-
Paris, FranceInstitut Curie
Jun 27, 2023
Germline and Somatic Pathogenic Variants in de Novo Metastatic
Active, not recruiting
- Metastatic Breast Cancer
- NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
-
Athens, GreeceEvangelia Moirogiorgou
Mar 7, 2023
Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,
Not yet recruiting
- Her 2 Positive Breast Cancer
- +2 more
- Sacituzumab Govitecan
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 25, 2023
Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)
Not yet recruiting
- Metastatic Breast Cancer
- DB-1303
- +3 more
-
Dallas, TexasTexas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023
Breast Cancer Trial (SHR-A1811, Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel)
Not yet recruiting
- Breast Cancer
- (no location specified)
Apr 3, 2023